Provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases.

Comprehensive biopharm operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the biopharm field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.